{"id":"https://openalex.org/G4889415366","display_name":"Role of the kallikrein-kinin system in diabetic retinopathy","description":"PUBLIC HEALTH RELEVANCE: Diabetes macular edema is a leading cause of vision loss. Recent studies have revealed that an enzyme named plasma kallikrein in increased in the vitreous of people with diabetic retinopathy and contributes impairment to retinal vascular dysfunction via a pathway that is VEGF independent. This grant will perform studies using both knockout animal models and pharmacological approaches to identify the mechanisms of plasma kallikrein's effects on the retina and potential crosstalk with the VEGF pathway.","funder_award_id":"R01EY019029","funder":{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","doi":"10.13039/100000053"},"funded_outputs":["https://openalex.org/W1501701662","https://openalex.org/W1525564944","https://openalex.org/W1835870821","https://openalex.org/W1839243089","https://openalex.org/W1915946772","https://openalex.org/W1970445900","https://openalex.org/W1987061162","https://openalex.org/W1995651511","https://openalex.org/W1996137482","https://openalex.org/W2003695991","https://openalex.org/W2006648038","https://openalex.org/W2007215692","https://openalex.org/W2008469275","https://openalex.org/W2010890173","https://openalex.org/W2035181421","https://openalex.org/W2040848516","https://openalex.org/W2041823317","https://openalex.org/W2047023619","https://openalex.org/W2047507856","https://openalex.org/W2060584283","https://openalex.org/W2065948752","https://openalex.org/W2069652858","https://openalex.org/W2080057916","https://openalex.org/W2104323245","https://openalex.org/W2105505313","https://openalex.org/W2105666938","https://openalex.org/W2126691218","https://openalex.org/W2132453656","https://openalex.org/W2139168430","https://openalex.org/W2140929680","https://openalex.org/W2157900496","https://openalex.org/W2166577272","https://openalex.org/W2202676181","https://openalex.org/W2346766681","https://openalex.org/W2520287050","https://openalex.org/W2540641851","https://openalex.org/W2541827212","https://openalex.org/W2964209469"],"funded_outputs_count":38,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"R01","start_date":"2008-09-01","end_date":"2018-03-31","start_year":2008,"end_year":2018,"landing_page_url":"https://reporter.nih.gov/project-details/7915462","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"LLOYD P","family_name":"AIELLO","orcid":null,"role_start":null,"affiliation":{"name":"JOSLIN DIABETES CENTER","country":"UNITED STATES","ids":null}},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G4889415366","primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9814,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9814,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"institution_awarded":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]}],"updated_date":"2026-10-16T03:01:01.000Z","created_date":"2026-10-09T19:56:01.000Z"}